Hormone receptor-positive (HR+) breast cancer is the predominant subtype with a favorable prognosis, accounting for approximately 70-80% of all diagnosed breast cancers, expressing at least one type of hormone receptor (ESR and PGR) 1-3. Here, NR4A1 is linked to breast cancer.